BlackRock
HURA

BlackRock’s TuHURA Biosciences HURA Stock Holding History

BlackRock’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Sell
690,088
-1,760,168
-72% -$4.1M ﹤0.01% 4219
2026
Q1 		$4.39M Buy
2,450,256
+883,892
+56% +$1.08M ﹤0.01% 3880
2025
Q4 		$1.19M Buy
1,566,364
+44,410
+3% +$85K ﹤0.01% 4263
2025
Q3 		$3.77M Buy
1,521,954
+183,728
+14% +$484K ﹤0.01% 3897
2025
Q2 		$2.98M Buy
1,338,226
+964,029
+258% +$3.26M ﹤0.01% 3949
2025
Q1 		$1.21M Sell
374,197
-17,110
-4% -$63.2K ﹤0.01% 4140
2024
Q4 		$1.6M Buy
+391,307
New +$2.08M ﹤0.01% 4096
2022
Q2 		– Sell
-52
Closed -$36K – 6020
2022
Q1 		$36K Sell
52
-3
-5% -$2.16K ﹤0.01% 5481
2021
Q4 		$49K Buy
55
+13
+31% +$17.6K ﹤0.01% 5404
2021
Q3 		$64K Sell
42
-1
-2% -$2.63K ﹤0.01% 5244
2021
Q2 		$172K Buy
+43
New +$124K ﹤0.01% 4928

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

BlackRock's HURA Position: Q2 2026 in Review

BlackRock reduced its TuHURA Biosciences (HURA) stake by 72% in Q2 2026, selling an estimated $4.1M and leaving 690,088 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #4219.

BlackRock first reported a position in HURA in Q2 2021 and has held it in 11 quarters since. The position peaked at $4.39M in Q1 2026. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • BlackRock held 690,088 shares of TuHURA Biosciences worth $1.61M as of Q2 2026.
  • BlackRock sold 1,760,168 TuHURA Biosciences shares in Q2 2026, an estimated $4.1M.
  • TuHURA Biosciences made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4219 holding.
  • BlackRock first reported a position in TuHURA Biosciences in Q2 2021 and has held it in 11 quarters since.
  • BlackRock's TuHURA Biosciences position peaked at $4.39M in Q1 2026.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.